People Who Care
Generous donors help to keep "best and brightest" young scientists at U-M
"I don’t do bricks and mortar — I’m a hands-on person and I like to know exactly who my money is going to,” says Edith Briskin, a Bloomfield Hills resident, philanthropist and artist.
“I was asked to be on the Taubman Institute board and thought it would be interesting to have a program that would support young researchers so they could get their own labs going," she said.
“That’s how the Emerging Scholars program started, and I funded the first one.”
The Edith Briskin/SKS Foundation Emerging Scholar, Dr. Erika Newman, assistant professor of pediatric surgery, is studying neuroblastoma – an often-fatal childhood cancer – at the cellular level with an eye toward new understanding and treatment of one of the most common pediatric cancers.
“I want to care for kids with solid tumors in the hospital and the operating room,” said Dr. Newman. “But I also wanted to start a research lab to get to the root of what causes these tumors.”
Leadership Advisory Board member Edith Briskin and Taubman Emerging scholar Dr. Erika Newman
Today, four Emerging Scholars -- young physician-scientists with promising research plans -- have established their labs at U-M. Many more outstanding candidates have been identified and hope to be matched with sponsors.
The program supports early-career doctor-scientists who still are accumulating the credentials required for larger grants; each receives $50,000 a year for three years to fund their research.
Before the founding of the Taubman Institute, Ms. Briskin had sought out other up-and-coming scientists to receive sponsorship from her family’s Shirley K. Schlafer Foundation, which donates money to pediatric cancer research and to arts programs for children at risk and disadvantaged children. Targeting funds for specific individuals is quite satisfying, she says.
Dr. Newman is using the Emerging Scholars grant to fund a lab staffed by one full-time assistant and several students; she spends about half of her days at the research bench and the rest of the time sees patients.
“Stem cells are expensive, and there’s a lot of trial and error,” she said. “The support of the Taubman Institute has allowed us to be creative, to take risks with our experiments and to follow my dream of tracing cancer back to its origins.
“They believe in us, and that inspires me.”
So far, funding has been established for three more Taubman Emerging Scholars, and numerous candidates for future grants have been identified.
Briskin said the personal connection with researchers she sponsors, through lunches, meetings and other events, adds an extra dimension to her philanthropy.
“I think the Taubman Institute is doing what medicine should be doing,” said Briskin. “These are doctors who see the patients, see the problems and want to solve them in the lab. It makes so much sense.
“It’s so important that we help the younger generation in their quest. In order to keep them at U-M we have to have programs like this.”
11 Taubman Scholars named to "Best Doctors in America" list
They're among 493 U-M physicians to receive the honor from their peers
Click here for the list.
Renowned diabetes expert to speak at U-M
David M. Nathan, M.D., of Harvard University to deliver two lectures April 18
Click here for details
U-M offers new early detection prostate cancer test
Research by Taubman Scholar Dr. Arul Chinnaiyan has let to the development of a new test for prostate cancer that is far more accurate than the standard PSA test, the University of Michigan has announced.
Click here to read more.
news & events
New Taubman Prize trophy debuts
The new trophy for the Taubman Prize for Excellence in Translational Medical Research, which was designed in consultation with institute founder Mr. A. Alfred Taubman, was presented at the institute's Oct. 11 symposium. The modern sculpture was created using a novel 3D printing technique.
Drug cuts risk of bone-marrow transplant side effect
Taubman Emerging Scholar Sung Won Choi, M.D., is the lead author of a new study that finds a new way to help prevent graft-vs-host disease in cancer patients receiving bone-marrow transplants.
Study: Two types of cancer stem cells lead to metastasis
Breast cancer stem cells exist in two different states and each state plays a role in how cancer spreads, according to a new study published by Taubman Senior Scholar Dr. Max Wicha.